TNX-103
TNX-103-08
Phase 3 small_molecule active
Quick answer
TNX-103 for Pulmonary Hypertension Associated With HFpEF is a Phase 3 program (small_molecule) at TENAX THERAPEUTICS, INC. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- TENAX THERAPEUTICS, INC.
- Indication
- Pulmonary Hypertension Associated With HFpEF
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active